Oncology PracticePersonalized cancer vaccine shows early promise across tumor typesApril 14, 2021Patient & Survivor CareMultiple MyelomaBreast CancerGenitourinary CancerLymphoma & Plasma Cell DisordersHead & Neck/Thyroid CancersLung Cancer
Oncology PracticeRankings of most common cancers to shift over next 20 yearsApril 14, 2021Breast CancerLung CancerMelanoma
Oncology PracticeSteroid-refractory pneumonitis from ICIs: Experience at major centersApril 9, 2021Patient & Survivor CareLung CancerNonmelanoma Skin CancerMelanomaGastrointestinal CancerHead & Neck/Thyroid CancersLymphoma & Plasma Cell Disorders
Oncology PracticeCancer screening stopped by pandemic: Repercussions to come?April 8, 2021Patient & Survivor CareLung CancerBreast CancerGastrointestinal CancerGynecologic CancerCOVID-19 UpdatesMixed Topics
HER2+ BC: Recurrence risk remains even after achieving pCR with neoadjuvant pertuzumab+trastuzumabApril 5, 2021Breast Cancer
Risk of 5-year local recurrence declines with event-free years in newly diagnosed breast cancerApril 5, 2021Breast Cancer
Breast MRI less accurate in predicting nodal status after neoadjuvant therapy in invasive lobular carcinomaApril 5, 2021Breast Cancer
Advanced breast cancer: Palbociclib+ET associated with low burden of cutaneous toxicitiesApril 5, 2021Breast Cancer
Node-negative ER+/HER2− breast cancer: Adjuvant ET improves OS in older patients with comorbiditiesApril 5, 2021Breast Cancer
Pembrolizumab fails to improve OS in patients with previously treated metastatic TNBCApril 5, 2021Breast Cancer
Early breast cancer: Updated MINDACT findings back omitting chemotherapy in low genomic riskApril 5, 2021Breast Cancer
Early breast cancer: Updated MINDACT findings back omitting chemotherapy in low genomic riskApril 5, 2021Breast Cancer
Oncology PracticeRisk-based mammography proposed for times of reduced capacityApril 2, 2021Breast Cancer
